US Medicare Insulin Demo Could Expand To Other Drugs

 
• By Derrick Gingery
  
Diabetes
Biosimilar insulin manufacturers are allowed to participate in the Part D demo, CMS Administrator Seema Verma said. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Medicare

More from Government Payers